1. Home
  2. WGSWW vs RXO Comparison

WGSWW vs RXO Comparison

Compare WGSWW & RXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGSWW
  • RXO
  • Stock Information
  • Founded
  • WGSWW 2017
  • RXO 2022
  • Country
  • WGSWW United States
  • RXO United States
  • Employees
  • WGSWW N/A
  • RXO N/A
  • Industry
  • WGSWW Retail: Computer Software & Peripheral Equipment
  • RXO
  • Sector
  • WGSWW Technology
  • RXO
  • Exchange
  • WGSWW Nasdaq
  • RXO Nasdaq
  • Market Cap
  • WGSWW N/A
  • RXO N/A
  • IPO Year
  • WGSWW N/A
  • RXO N/A
  • Fundamental
  • Price
  • WGSWW $0.21
  • RXO $19.09
  • Analyst Decision
  • WGSWW
  • RXO Hold
  • Analyst Count
  • WGSWW 0
  • RXO 17
  • Target Price
  • WGSWW N/A
  • RXO $26.13
  • AVG Volume (30 Days)
  • WGSWW 36.6K
  • RXO 1.3M
  • Earning Date
  • WGSWW 02-18-2025
  • RXO 05-01-2025
  • Dividend Yield
  • WGSWW N/A
  • RXO N/A
  • EPS Growth
  • WGSWW N/A
  • RXO N/A
  • EPS
  • WGSWW N/A
  • RXO N/A
  • Revenue
  • WGSWW $305,450,000.00
  • RXO $4,550,000,000.00
  • Revenue This Year
  • WGSWW N/A
  • RXO $47.30
  • Revenue Next Year
  • WGSWW N/A
  • RXO $8.19
  • P/E Ratio
  • WGSWW N/A
  • RXO N/A
  • Revenue Growth
  • WGSWW 50.79
  • RXO 15.87
  • 52 Week Low
  • WGSWW $0.17
  • RXO $17.50
  • 52 Week High
  • WGSWW $0.21
  • RXO $32.82
  • Technical
  • Relative Strength Index (RSI)
  • WGSWW N/A
  • RXO 41.56
  • Support Level
  • WGSWW N/A
  • RXO $18.72
  • Resistance Level
  • WGSWW N/A
  • RXO $19.42
  • Average True Range (ATR)
  • WGSWW 0.00
  • RXO 0.75
  • MACD
  • WGSWW 0.00
  • RXO 0.20
  • Stochastic Oscillator
  • WGSWW 0.00
  • RXO 64.45

About WGSWW GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

Share on Social Networks: